Mouse OPG (TNFRSF11B) / Osteoprotegerin ELISA Kit PicoKine®

SKU:BHE21000471
Overview
Click light‑blue chips for details
Mouse OPG (TNFRSF11B) / Osteoprotegerin PicoKine® Quick ELISA kit is designed for quantitative detection of OPG (TNFRSF11B) / Osteoprotegerin. Suitable for cell culture supernatants, serum and plasma (EDTA). Optimized for a streamlined sandwich ELISA workflow with high signal-to-noise and reproducible results. Reported sensitivity: <5 pg/ml.
Target TNFRSF11B
Reactivity Mouse
Sample Type(s) cell culture supernatants, serum and plasma (EDTA).
Assay Type Sandwich ELISA
Sensitivity <5 pg/ml
Detection Range 93.7 pg/ml - 6,000 pg/ml
Assay Time ~3.5 hours
Options selector
Catalog no. Size
EK0481 96 wells/kit, with removable strips.
Available Options

Select from the available variant options shown for this product. Availability and lead time may vary by option.

  • Options: Size: 96 wells/kit, with removable strips..
  • Lead time: items “in stock at manufacturer” typically ship in 5–7 business days.
  • Storage: Store at 4℃ for 6 months, at -20℃ for 12 months. Avoid multiple freeze-thaw cycles (Ships with gel ice, can store for up to 3 days in room temperature. Freeze upon receiving.); cold-chain shipment (typically with ice packs) is expected.
  • Please ensure someone is available to receive temperature-sensitive deliveries promptly.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Mfr No EK0481
Alternative Names Tumor necrosis factor receptor superfamily member 11B;Osteoclastogenesis inhibitory factor;Osteoprotegerin;Tnfrsf11b;Ocif, Opg;
Assay Time
  • ~3.5 hours
Assay Type
  • Sandwich ELISA
Detection Range 93.7 pg/ml - 6,000 pg/ml
Expression System
  • NS0
Gene ID 18383
Immunogen Expression system for standard: NS0; Immunogen sequence: E22-L401
Product Type
  • ELISA Kits
  • PicoKine® ELISA Kitss
Reactivity
  • Mouse
Sample Type(s) cell culture supernatants, serum and plasma (EDTA).
Sensitivity <5 pg/ml
Storage Store at 4℃ for 6 months, at -20℃ for 12 months. Avoid multiple freeze-thaw cycles (Ships with gel ice, can store for up to 3 days in room temperature. Freeze upon receiving.)
Target TNFRSF11B
UniProt # O08712

Background

Also known as: Tumor necrosis factor receptor superfamily member 11B, Osteoclastogenesis inhibitory factor, Osteoprotegerin, Tnfrsf11b, Ocif, Opg.

Mouse OPG (TNFRSF11B) / Osteoprotegerin (TNFRSF11B) is an established target in many assay panels, supporting hypothesis testing across diverse biological systems. This target is frequently investigated in Molecular & Cellular Biology research contexts. Cytokines and chemokines act as soluble messengers that coordinate immune cell activation, trafficking, and effector functions. Their concentrations can change rapidly in response to infection, tissue injury, or immune stimulation.

Biological function and signaling context

In immune signaling networks, cytokine production is often induced by pattern-recognition pathways and inflammatory transcriptional programs, while feedback regulators can dampen responses to restore homeostasis. Chemokine gradients guide leukocyte migration, influencing which cell populations accumulate at a site and how long they persist.

Why it matters in research

  • Immune activation readout: Shifts in abundance can reflect pathway engagement and cellular activation state.
  • Microenvironment profiling: Levels can help characterize inflammatory tone in tissues or biofluids.
  • Response monitoring: Time-course measurements support interpretation of stimulus, treatment, or infection models.

Disease and translational relevance

Many cytokines and chemokines are reported to associate with inflammatory, autoimmune, infectious, and oncology-related processes. In research settings, interpreting changes benefits from pairing this analyte with complementary markers (e.g., upstream triggers, downstream effectors, and cell-type indicators) and considering matrix effects.

Sample data

Concentration (pg/ml)093.8187.5375750150030006000
O.D.0.0140.0710.1380.2750.5360.921.5322.158

Intra/inter assay consistency

Intra-Assay PrecisionInter-Assay Precision
Sample123123
n161616242424
Mean (pg/ml)13380035351397673643
Standard deviation5.8554.4187.357.3955.39225.86
CV (%)4.4%6.8%5.3%4.6%7.3%6.2%

Kit components

Description|Quantity Pre-coated 96-well strip microplate|1 Standard|2 vials Biotinylated antibody (100x)|100ul Avidin-Biotin-Peroxidase Complex (100x)|100ul Sample Diluent|30ml Antibody Diluent|12ml Avidin-Biotin-Peroxidase Diluent|12ml Color Developing Reagent (TMB)|10ml Stop Solution|10ml Wash Buffer (25x)|20ml Adhesive plate sealers|4

Materials required but not provided

  • Microplate Reader capable of reading absorbance at 450nm.
  • Incubator.
  • Automated plate washer (optional).
  • Pipettes and pipette tips capable of precisely dispensing 0.5 µl through 1 ml volumes of aqueous solutions.
  • Multichannel pipettes are recommended for large amount of samples.
  • Deionized or distilled water.
  • 500ml graduated cylinders.
  • Test tubes for dilution.
How many samples can I run per plate?
Each PicoKine® kit (96-well format) typically accommodates a 7-point standard curve in duplicate, 2 non-specific binding wells, and up to 39 unknown samples in duplicate. Exact capacity may vary by kit — refer to the datasheet.
What sample dilution should I use?
Boster recommends performing a pilot study first: run serial dilutions of your samples (e.g. 1:2, 1:4, 1:8, 1:16) to identify the range that falls within the standard curve. This is important because sample matrix and protein expression levels vary significantly by experiment.
Why is my signal weak or absent?
The most common causes are: (1) target protein below the kit's detection limit — try concentrating samples or reducing dilution; (2) reagents not at room temperature before use; (3) insufficient incubation time; (4) expired or contaminated reagents. See Boster's full ELISA troubleshooting guide at bosterbio.com/protocol-and-troubleshooting/picokine-elisa-troubleshooting.
Why is my background signal high?
High background is typically caused by insufficient washing (ensure thorough plate draining after each wash step), excess antibody concentration, or contaminated TMB substrate. Increase the number of wash cycles or reduce antibody concentration. Always use fresh substrate solution.
Are the kit components sterile?
Components are bottled using aseptic techniques and heat-treated vials, but are not guaranteed sterile. If your experiment requires sterile material, filter through a 0.2 µm membrane designed for biological fluids before use.
How do I analyze my ELISA results?
Plot absorbance (OD 450 nm) against standard concentrations and fit a 4-parameter logistic (4PL) or sigmoidal curve. Read unknown sample concentrations from the curve. Boster provides a free online ELISA data analysis tool at bosterbio.com/biology-research-tools/elisa-data-analysis-online.
How should I store samples before running the assay?
Aliquot samples before freezing to avoid repeated freeze-thaw cycles, which can degrade the target protein. Store aliquots at -80°C for long-term use. Serum and plasma should be collected, processed, and stored under consistent conditions to minimise pre-analytical variability.
What positive and negative controls should I include?
Include a positive control (a sample known to contain the target protein at a measurable level) and a negative control (sample matrix without the target, or a sample from a species the kit does not cross-react with). Running controls in every assay validates the assay performance and flags plate-to-plate variability.

Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.

  1. Liu et al. (2024). Stephanine Protects Against Osteoporosis by Suppressing Osteoclastogenesis via Inhibition of the RANKL—RANK Interaction. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE.
  2. Marianne et al. (2024). Differential effects of alendronate on chondrocytes, cartilage matrix and subchondral bone structure in surgically induc…. Scientific Reports.
  3. Zhang et al. (2023). Plasma TNFRSF11B as a New Predictive Inflammatory Marker of Sepsis–ARDS with Endothelial Dysfunction. JOURNAL OF PROTEOME RESEARCH.
  4. Huang et al. (2022). Oroxin B Attenuates Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Formation and Activity. Drug Design Development and Therapy.
  5. Yang et al. (2022). NTCP Deficiency Affects the Levels of Circulating Bile Acids and Induces Osteoporosis. Frontiers in Endocrinology.
  6. Deepak et al. (2022). IFT80 negatively regulates osteoclast differentiation via association with Cbl-b to disrupt TRAF6 stabilization and acti…. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA.
  7. Li et al. (2022). IFT20 governs mesenchymal stem cell fate through positively regulating TGF-β-Smad2/3-Glut1 signaling mediated glucose me…. Redox Biology.
  8. Li et al. (2022). Deletion of Trp53 and Rb1 in Ctsk-expressing cells drives osteosarcoma progression by activating glucose metabolism and …. MedComm.
  9. Li et al. (2021). Introduction of a Cys360Tyr Mutation in ANO5 Creates a Mouse Model for Gnathodiaphyseal Dysplasia. JOURNAL OF BONE AND MINERAL RESEARCH.
  10. Hui et al. (2021). Inhibiting Monoacylglycerol Lipase Suppresses RANKL-Induced Osteoclastogenesis and Alleviates Ovariectomy-Induced Bone L…. Frontiers in Cell and Developmental Biology.
  11. Xu et al. (2020). Acanthopanax senticosus aqueous extract ameliorates ovariectomy-induced bone loss in middle-aged mice by inhibiting the …. Food & Function.
  12. Hui et al. (2020). NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis. Cell Death & Disease.
  13. Zhu et al. (2019). Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss. BIOMEDICINE & PHARMACOTHERAPY.
  14. Kazuaki et al. (2019). Bone loss caused by dopaminergic degeneration and levodopa treatment in Parkinson’s disease model mice. Scientific Reports.
  15. Liu et al. (2018). Hesperetin suppresses RANKL-induced osteoclastogenesis and ameliorates lipopolysaccharide-induced bone loss. JOURNAL OF CELLULAR PHYSIOLOGY.
  16. Cong et al. (2018). Effects of Taxifolin on Osteoclastogenesis in vitro and in vivo. Frontiers in Pharmacology.
  17. Zhang et al. (2018). (2R,3R)Dihydromyricetin inhibits osteoclastogenesis and bone loss through scavenging LPS-induced oxidative stress and NF…. JOURNAL OF CELLULAR BIOCHEMISTRY.
  18. Song et al. (2018). REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially viaFABP4 upregulation. FASEB JOURNAL.
  19. Libo et al. (2017). Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity. Frontiers in Pharmacology.
  20. Jiachao et al. (2017). Meclizine Prevents Ovariectomy-Induced Bone Loss and Inhibits Osteoclastogenesis Partially by Upregulating PXR. Frontiers in Pharmacology.
  21. Kong et al. (2017). Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytok…. INTERNATIONAL IMMUNOPHARMACOLOGY.
  22. Dong et al. (2017). Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss t…. CELLULAR SIGNALLING.
  23. Liu et al. (2017). Lipoxin A4 suppresses osteoclastogenesis in RAW264.7 cells and prevents ovariectomy-induced bone loss. EXPERIMENTAL CELL RESEARCH.
  24. Yong et al. (2015). Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss. Scientific Reports.
  25. Guan et al. (2014). Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss. FASEB JOURNAL.
  26. Mai et al. (2011). Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. JOURNAL OF CELLULAR BIOCHEMISTRY.
  27. (2025). Up-regulation of Ifi27l2a expression in bone marrow monocytes contributes to glucocorticoid-induced bone loss.
Matches this product
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
15%OFF
15% Off Cancer Antibodies
Ends Sep 30 ONCO15
10% OFF
10% OFF CELL LINES-Limited-Time Offer
Ends Sep 30 CELL10
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today